Literature DB >> 30191984

Fusobacterium nucleatum and colorectal cancer: A mechanistic overview.

Nasser Hashemi Goradel1, Siamak Heidarzadeh2, Samira Jahangiri3, Bagher Farhood4, Keywan Mortezaee5, Neda Khanlarkhani6, Babak Negahdari1.   

Abstract

Colorectal cancer (CRC) is the third most prevalent cancer in the world. There are many risk factors involved in CRC. According to recent findings, the tumor microenvironment and feces samples of patients with CRC are enriched by Fusobacterium nucleatum. Thus, F. nucleatum is proposed as one of the risk factors in the initiation and progression of CRC. The most important mechanisms of Fusobacterium nucleatum involved in CRC carcinogenesis are immune modulation (such as increasing myeloid-derived suppressor cells and inhibitory receptors of natural killer cells), virulence factors (such as FadA and Fap2), microRNAs (such as miR-21), and bacteria metabolism. The aim of this review was to evaluate the mechanisms underlying the action of F. nucleatum in CRC.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  Fusobacterium nucleatum; carcinogenesis; colorectal cancer (CRC); tumor microenvironment

Mesh:

Substances:

Year:  2018        PMID: 30191984     DOI: 10.1002/jcp.27250

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  35 in total

1.  Fusobacterium Nucleatum Is a Risk Factor for Metastatic Colorectal Cancer.

Authors:  Wen-Dan Chen; Xin Zhang; Ya-Ping Zhang; Cong-Bo Yue; Yan-Lei Wang; Hong-Wei Pan; Yan-Li Zhang; Hui Liu; Yi Zhang
Journal:  Curr Med Sci       Date:  2022-06-08

Review 2.  Key promoters of tumor hallmarks.

Authors:  Keywan Mortezaee; Jamal Majidpoor
Journal:  Int J Clin Oncol       Date:  2021-11-13       Impact factor: 3.402

Review 3.  Fusobacterium nucleatum: a new player in regulation of cancer development and therapeutic response.

Authors:  Tengda Zhao; Xueping Wang; Liwu Fu; Ke Yang
Journal:  Cancer Drug Resist       Date:  2022-05-12

Review 4.  The Influence of Nutrition on Intestinal Permeability and the Microbiome in Health and Disease.

Authors:  Orsolya Inczefi; Péter Bacsur; Tamás Resál; Csilla Keresztes; Tamás Molnár
Journal:  Front Nutr       Date:  2022-04-25

5.  Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.

Authors:  Aref Shariati; Shabnam Razavi; Ehsanollah Ghaznavi-Rad; Behnaz Jahanbin; Abolfazl Akbari; Samira Norzaee; Davood Darban-Sarokhalil
Journal:  Infect Agent Cancer       Date:  2021-06-09       Impact factor: 2.965

6.  A Comparison Study of Age and Colorectal Cancer-Related Gut Bacteria.

Authors:  Yu-Kun Zhang; Qian Zhang; Yu-Liuming Wang; Wei-Yuan Zhang; Han-Qing Hu; Hong-Yu Wu; Xiang-Zong Sheng; Kang-Jia Luo; Hao Zhang; Meng Wang; Rui Huang; Gui-Yu Wang
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

7.  Microbiome profile associated with malignant pleural effusion.

Authors:  Samira Shojaee; Anukriti Sharma; Neil Gottel; Trinidad Sanchez; Jack A Gilbert; Najib M Rahman
Journal:  PLoS One       Date:  2020-05-08       Impact factor: 3.240

Review 8.  A Reasonable Diet Promotes Balance of Intestinal Microbiota: Prevention of Precolorectal Cancer.

Authors:  Pan Huang; Yi Liu
Journal:  Biomed Res Int       Date:  2019-07-25       Impact factor: 3.411

Review 9.  Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy.

Authors:  Kumar Ganesan; Songhe Guo; Sundaz Fayyaz; Ge Zhang; Baojun Xu
Journal:  Cancers (Basel)       Date:  2019-10-18       Impact factor: 6.639

Review 10.  Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Majid Alipour
Journal:  J Gastrointest Cancer       Date:  2020-09-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.